These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 20725077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE.
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Toxicology and drugs of abuse testing at the point of care.
    Yang JM.
    Clin Lab Med; 2001 Jun; 21(2):363-74, ix-x. PubMed ID: 11396089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U, Zhang YV.
    Methods Mol Biol; 2016 Jun; 1383():1-10. PubMed ID: 26660168
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods.
    von Lode P.
    Clin Biochem; 2005 Jul; 38(7):591-606. PubMed ID: 16009140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R, Pesce A, West C, Crews B, Mikel C, Almazan P, Rosenthal M, Latyshev S.
    Pain Physician; 2010 Jul; 13(1):71-8. PubMed ID: 20119465
    [Abstract] [Full Text] [Related]

  • 14. Drug-testing methods and clinical interpretations of test results.
    Kapur BM.
    Bull Narc; 1993 Jul; 45(2):115-54. PubMed ID: 7920539
    [Abstract] [Full Text] [Related]

  • 15. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM, Goldberger BA, Bertholf RL.
    J Opioid Manag; 2015 Jul; 11(1):37-44. PubMed ID: 25750163
    [Abstract] [Full Text] [Related]

  • 16. The utility of immunoassays for urine drug testing.
    Melanson SE.
    Clin Lab Med; 2012 Sep; 32(3):429-47. PubMed ID: 22939301
    [Abstract] [Full Text] [Related]

  • 17. Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing.
    Fleisher M, Schwartz MK.
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S18-25. PubMed ID: 7484944
    [Abstract] [Full Text] [Related]

  • 18. Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry.
    Pelander A, Ristimaa J, Rasanen I, Vuori E, Ojanperä I.
    Ther Drug Monit; 2008 Dec; 30(6):717-24. PubMed ID: 18806694
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay.
    Lewandrowski K, Flood J, Finn C, Tannous B, Farris AB, Benzer TI, Lee-Lewandrowski E.
    Am J Clin Pathol; 2008 May; 129(5):796-801. PubMed ID: 18426741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.